Dubey Ashish Kumar, Podia Mansi, Raut Sachin, Singh Sanpreet, Pinnaka Anil Kumar, Khatri Neeraj
IMTECH Centre for Animal Resources and Experimentation (iCARE), Council of Scientific and Industrial Research-Institute of Microbial Technology (CSIR-IMTECH), Chandigarh, India.
Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, India.
Front Pharmacol. 2021 Nov 4;12:728614. doi: 10.3389/fphar.2021.728614. eCollection 2021.
MTCC 2621 is a well-characterized probiotic strain and is reported to possess many health benefits. However, the wound healing potential of this probiotic is yet to be explored. Here, we have assessed the antibacterial, antioxidant, and wound healing activities of cell-free supernatant of MTCC 2621 (Lp2621). Lp2621 exhibited excellent antibacterial activity against the indicator bacteria in the agar well diffusion assay. Lp2621 did not show any hemolytic activity. The safety of Lp2621 gel was established using the skin irritation assay in BALB/c mice, and no dermal reactions were observed. The supernatant showed 60-100% protection of A549 cells against HO-induced stress. In the scratch assay, Lp2621 accelerated wound healing after 24 h of treatment. The percent wound healing was significantly higher in cells treated with Lp2621 at 18-24 h posttreatment. In an excision wound healing in mice, topical application of Lp2621 gel showed faster healing than the vehicle- and betadine-treated groups. Similar wound healing activity was observed in wounds infected with . Histological examination revealed better wound healing in Lp2621-treated mice. Topical treatment of the wounds with Lp2621 gel resulted in the upregulation of pro-inflammatory cytokine IL-6 in the early phase of wound healing and enhanced IL-10 expression in the later phase. These findings unveil a protective role of Lp2621 against bacterial infection, oxidative stress, and wound healing.
MTCC 2621是一种特征明确的益生菌菌株,据报道具有许多健康益处。然而,这种益生菌的伤口愈合潜力尚未得到探索。在此,我们评估了MTCC 2621(Lp2621)无细胞上清液的抗菌、抗氧化和伤口愈合活性。在琼脂孔扩散试验中,Lp2621对指示菌表现出优异的抗菌活性。Lp2621未表现出任何溶血活性。通过在BALB/c小鼠中进行皮肤刺激试验确定了Lp2621凝胶的安全性,未观察到皮肤反应。该上清液对HO诱导的应激使A549细胞有60 - 100%的保护作用。在划痕试验中,治疗24小时后Lp2621加速了伤口愈合。在治疗后18 - 24小时,用Lp2621处理的细胞伤口愈合百分比显著更高。在小鼠切除伤口愈合实验中,局部应用Lp2621凝胶显示出比赋形剂和碘伏处理组更快的愈合速度。在用[未提及的感染物]感染的伤口中观察到类似的伤口愈合活性。组织学检查显示Lp2621处理的小鼠伤口愈合更好。用Lp2621凝胶局部治疗伤口导致伤口愈合早期促炎细胞因子IL - 6上调,后期IL - 10表达增强。这些发现揭示了Lp2621在抵抗细菌感染、氧化应激和伤口愈合方面的保护作用。